KEGG   PATHWAY: mcc05140
Entry
mcc05140                    Pathway                                
Name
Leishmaniasis - Macaca mulatta (rhesus monkey)
Description
Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.
Class
Human Diseases; Infectious disease: parasitic
Pathway map
mcc05140  Leishmaniasis
mcc05140

Disease
H00359  Leishmaniasis
Organism
Macaca mulatta (rhesus monkey) [GN:mcc]
Gene
100187587  MAMU-DRA; mamu class II histocompatibility antigen, DR alpha chain precursor [KO:K06752]
100423877  IFNGR1; interferon gamma receptor 1 precursor [KO:K05132]
100425937  [KO:K03231]
100428228  MAMU-DRB5; LOW QUALITY PROTEIN: MHC class II antigen, Mamu-DRB5 [KO:K06752]
100428435  [KO:K06752]
100428619  MARCKSL1; MARCKS-related protein [KO:K13536]
100429857  MAMU-DMB; major histocompatibility complex, class II, DM beta precursor [KO:K06752]
106992315  TGFB1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375]
106996003  [KO:K06856]
106997902  [KO:K06752]
106999628  [KO:K06856]
114669810  [KO:K06752]
114672301  [KO:K04375]
114673005  [KO:K13241] [EC:1.14.13.39]
114675357  [KO:K06752]
114675805  [KO:K06856]
114679736  [KO:K06856]
574281  IL4; interleukin-4 precursor [KO:K05430]
574282  IFNG; interferon gamma precursor [KO:K04687]
574290  TLR2; toll-like receptor 2 precursor [KO:K10159]
574312  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
574360  TLR4; toll-like receptor 4 precursor [KO:K10160]
677689  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
692100  MAMU-DRB1; major histocompatibility complex, class II, DR beta 1 precursor [KO:K06752]
693650  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
694184  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
694207  NCF1; neutrophil cytosol factor 1 [KO:K08011]
694679  [KO:K03231]
694747  IL12B; interleukin-12 subunit beta precursor [KO:K05425]
694844  NFKBIB; NF-kappa-B inhibitor beta [KO:K02581]
694931  IL10; interleukin-10 precursor [KO:K05443]
695335  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
695612  NCF4; neutrophil cytosol factor 4 isoform X1 [KO:K08012]
696494  MYD88; myeloid differentiation primary response protein MyD88 [KO:K04729]
696542  CYBB; cytochrome b-245 heavy chain [KO:K21421] [EC:1.-.-.-]
696748  [KO:K08009]
696875  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
696946  EEF1A2; elongation factor 1-alpha 2 [KO:K03231]
698569  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
699489  IFNGR2; interferon gamma receptor 2 [KO:K05133]
699919  IRAK1; interleukin-1 receptor-associated kinase 1 [KO:K04730] [EC:2.7.11.1]
700193  IL1A; interleukin-1 alpha precursor [KO:K04383]
700568  IRAK4; interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
701195  PRKCB; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
702077  FOS; proto-oncogene c-Fos [KO:K04379]
703101  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
703205  IL12A; interleukin-12 subunit alpha [KO:K05406]
703239  TGFB3; transforming growth factor beta-3 precursor [KO:K13377]
703409  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
703613  C3; complement C3 [KO:K03990]
704701  IL1B; interleukin-1 beta precursor [KO:K04519]
704745  ITGA4; integrin alpha-4 [KO:K06483]
706921  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
707540  TGFB2; transforming growth factor beta-2 precursor [KO:K13376]
708938  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
709017  [KO:K03231]
710324  NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580]
710577  ITGB2; integrin beta-2 isoform X1 [KO:K06464]
712610  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
714374  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
714419  [KO:K06856]
714664  FCGR1A; high affinity immunoglobulin gamma Fc receptor I precursor [KO:K06498]
714832  ITGAM; integrin alpha-M isoform X3 [KO:K06461]
715052  NCF2; neutrophil cytosol factor 2 isoform X1 [KO:K08010]
715467  TNF; tumor necrosis factor [KO:K03156]
715745  MAPK12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
715794  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
715919  RELA; transcription factor p65 isoform X1 [KO:K04735]
716010  EEF1A1; elongation factor 1-alpha 1 [KO:K03231]
716452  JUN; transcription factor AP-1 [KO:K04448]
716671  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
716823  MAMU-DQB1; major histocompatibility complex, class II, DQ beta 1 precursor [KO:K06752]
716907  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
717702  MAMU-DOB; major histocompatibility complex, class II, DO beta precursor [KO:K06752]
717870  MAMU-DMA; major histocompatibility complex, class II, DM alpha precursor [KO:K06752]
717947  MAMU-DOA; major histocompatibility complex, class II, DO alpha precursor [KO:K06752]
717969  MAMU-DPB; major histocompatibility complex, class II, DP beta [KO:K06752]
717992  MAMU-DPA; major histocompatibility complex, class II, DP alpha [KO:K06752]
718120  CR1; complement receptor type 1 [KO:K04011]
718976  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
719085  MAPK13; mitogen-activated protein kinase 13 isoform X1 [KO:K04441] [EC:2.7.11.24]
719996  FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a precursor [KO:K06472]
720006  FCGR3; low affinity immunoglobulin gamma Fc region receptor III isoform C precursor [KO:K06463]
720452  [KO:K06856]
720582  MAMU-DQA1; major histocompatibility complex, class II, DQ alpha 1 precursor [KO:K06752]
720904  [KO:K06856]
720935  [KO:K06856]
720985  [KO:K06856]
721002  [KO:K06856]
721083  [KO:K06856]
722278  [KO:K06856]
Compound
C00076  Calcium cation
C00195  N-Acylsphingosine
C00219  Arachidonate
C00533  Nitric oxide
C00584  Prostaglandin E2
C02737  Phosphatidylserine
Reference
  Authors
Cunningham AC
  Title
Parasitic adaptive mechanisms in infection by leishmania.
  Journal
Exp Mol Pathol 72:132-41 (2002)
DOI:10.1006/exmp.2002.2418
Reference
  Authors
Nandan D, Knutson KL, Lo R, Reiner NE
  Title
Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.
  Journal
J Leukoc Biol 67:464-70 (2000)
DOI:10.1002/jlb.67.4.464
Reference
PMID:7591091
  Authors
Nandan D, Reiner NE
  Title
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.
  Journal
Infect Immun 63:4495-500 (1995)
DOI:10.1128/IAI.63.11.4495-4500.1995
Reference
  Authors
Nandan D, Lo R, Reiner NE
  Title
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.
  Journal
Infect Immun 67:4055-63 (1999)
DOI:10.1128/IAI.67.8.4055-4063.1999
Reference
PMID:7916951
  Authors
Reiner NE
  Title
Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.
  Journal
Immunol Today 15:374-81 (1994)
DOI:10.1016/0167-5699(94)90176-7
Reference
  Authors
Nandan D, Reiner NE
  Title
Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.
  Journal
Clin Immunol 114:266-77 (2005)
DOI:10.1016/j.clim.2004.07.017
Reference
  Authors
Kima PE
  Title
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.
  Journal
Int J Parasitol 37:1087-96 (2007)
DOI:10.1016/j.ijpara.2007.04.007
Reference
  Authors
Forget G, Gregory DJ, Olivier M
  Title
Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.
  Journal
J Biol Chem 280:30542-9 (2005)
DOI:10.1074/jbc.M414126200
Reference
  Authors
Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R
  Title
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
  Journal
J Immunol 173:3297-304 (2004)
DOI:10.4049/jimmunol.173.5.3297
Reference
  Authors
Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V
  Title
Toll-like receptors and leishmaniasis.
  Journal
Infect Immun 76:866-72 (2008)
DOI:10.1128/IAI.01090-07
Reference
  Authors
Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I
  Title
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.
  Journal
J Leukoc Biol 76:48-57 (2004)
DOI:10.1189/jlb.1003484
Reference
  Authors
Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY
  Title
Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.
  Journal
J Immunol 163:6403-12 (1999)
Reference
  Authors
Olivier M, Gregory DJ, Forget G
  Title
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.
  Journal
Clin Microbiol Rev 18:293-305 (2005)
DOI:10.1128/CMR.18.2.293-305.2005
Reference
  Authors
Matte C, Maion G, Mourad W, Olivier M
  Title
Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.
  Journal
Parasite Immunol 23:177-84 (2001)
DOI:10.1046/j.1365-3024.2001.00372.x
Reference
  Authors
Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S
  Title
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.
  Journal
Infect Immun 70:6828-38 (2002)
DOI:10.1128/IAI.70.12.6828-6838.2002
Reference
PMID:9504340
  Authors
Bogdan C, Rollinghoff M
  Title
The immune response to Leishmania: mechanisms of parasite control and evasion.
  Journal
Int J Parasitol 28:121-34 (1998)
DOI:10.1016/S0020-7519(97)00169-0
Reference
  Authors
Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M
  Title
Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).
  Journal
Immunology 127:123-33 (2009)
DOI:10.1111/j.1365-2567.2008.02929.x
Reference
  Authors
Alexander J, Satoskar AR, Russell DG
  Title
Leishmania species: models of intracellular parasitism.
  Journal
J Cell Sci 112 Pt 18:2993-3002 (1999)
Reference
  Authors
Denkers EY, Butcher BA
  Title
Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
  Journal
Trends Parasitol 21:35-41 (2005)
DOI:10.1016/j.pt.2004.10.004
Reference
  Authors
Lodge R, Diallo TO, Descoteaux A
  Title
Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
  Journal
Cell Microbiol 8:1922-31 (2006)
DOI:10.1111/j.1462-5822.2006.00758.x
Reference
  Authors
de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA
  Title
Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.
  Journal
Curr Biol 11:1870-3 (2001)
DOI:10.1016/S0960-9822(01)00563-2
Reference
  Authors
Kane MM, Mosser DM
  Title
Leishmania parasites and their ploys to disrupt macrophage activation.
  Journal
Curr Opin Hematol 7:26-31 (2000)
DOI:10.1097/00062752-200001000-00006
Reference
  Authors
de Almeida MC, Vilhena V, Barral A, Barral-Netto M
  Title
Leishmanial infection: analysis of its first steps. A review.
  Journal
Mem Inst Oswaldo Cruz 98:861-70 (2003)
DOI:10.1590/S0074-02762003000700001
Related
pathway
mcc00590  Arachidonic acid metabolism
mcc04010  MAPK signaling pathway
mcc04020  Calcium signaling pathway
mcc04120  Ubiquitin mediated proteolysis
mcc04145  Phagosome
mcc04610  Complement and coagulation cascades
mcc04620  Toll-like receptor signaling pathway
mcc04630  JAK-STAT signaling pathway
mcc04666  Fc gamma R-mediated phagocytosis
KO pathway
ko05140   

DBGET integrated database retrieval system